Intelligent Implants is a Swedish‑Irish smart orthopaedics startup developing SmartFuse, a wirelessly enabled platform designed to remotely stimulate, control, and monitor bone growth with an initial indication in lumbar spinal fusion. The company positions SmartFuse to accelerate bone healing and provide remote monitoring to support real‑time clinical decision‑making, aiming to reduce revision surgeries and improve patient outcomes. SmartFuse is not approved for human use or sale in any geography. Intelligent Implants has received Breakthrough Device Designation from the U.S. Food and Drug Administration, which the company cites as endorsement of its clinical pathway. The newly awarded €4.5 million blended financing from the EU EIC Accelerator will be used to accelerate completion of a clinical pilot trial and to prepare a pivotal study for the SmartFuse system. The company operates at the intersection of digital health and orthopaedics and targets unmet needs in spinal fusion and degenerative disc disease to lower financial and human costs of care.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2021